Since its inception in 2013, Nourish Pharmaceutical has been dedicated to delivering high-quality pharmaceutical solutions. Here are the key milestones in our journey꞉
2023Launch of State-of-the-Art Manufacturing Facility for Tablets, Capsules, and Liquid Orals
Opened a state-of-the-art manufacturing plant compliant with global standards for tablets, capsules, and liquid orals.2019Production Capacity Boosted to 70% Through Domestic Expansion
Increased production capacity to 70% through significant domestic expansion.2017Launch of Small-Scale Plant Boosts Tablet and Liquid Oral Production Efficiency
Opened a small-scale manufacturing plant for tablets and liquid orals, enhancing our production efficiency.2015Global Expansion with Two New Pediatric Products
Launched two pediatric products internationally, expanding our product portfolio.2014Successful Global Launch with First International Product Registration
Successfully registered our first international product, marking our entry into the global market.2013Foundation Laid for Strong Market Presence with Private Limited Status
Established as a private limited company, setting the stage for a strong market presence.
Each milestone highlights our commitment to quality and innovation, driving our mission to make essential medicines accessible globally. This ongoing journey reflects both our past achievements and our future aspirations in the pharmaceutical industry.
Recognition
Nourish Pharmaceutical has garnered widespread recognition aligning with our strategic milestones. Our 2023 inauguration of a state-of-the-art facility met with accolades for global standards compliance and quality assurance.
Our innovative pediatric products launched in 2015 earned awards for healthcare innovation.
The significant expansion in 2019 highlighted our operational excellence, while our commitment
to sustainable manufacturing has been acknowledged with environmental awards.
Additionally, our efforts to enhance healthcare accessibility have been recognized with community impact awards. These accolades underscore our continuous commitment to excellence and innovation in the pharmaceutical industry.